SABS icon

SAB Biotherapeutics
SABS

Overview Fund Trends Analyst Outlook Journalist POV

26 hedge funds and large institutions have $65.9M invested in SAB Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.74M
2
+$5.89M
3
+$5.84M
4
SCM
Shaolin Capital Management
Florida
+$5.11M
5
MP
Mangrove Partners
Connecticut
+$5.09M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.74M
2
$5.89M
3
$5.84M
4
$5.11M
5
$5.09M
6
$4.91M
7
$4.91M
8
$4.42M
9
$3.7M
10
$3.53M
11
$3.44M
12
$2.94M
13
$2.84M
14
$1.51M
15
$1.48M
16
$982K
17
$721K
18
$452K
19
$442K
20
$264K
21
$246K
22
$182K
23
$100K
24
$98K
25
$9K
1
2